Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy

被引：0
|
作者：
Azeez Aranmolate
Nathaniel Tse
Holly Colognato
机构：
[1] Stony Brook University,Department of Pharmacological Sciences
来源：
BMC Neuroscience | / 18卷
关键词：
Duchenne muscular dystrophy; Dystrophin; Oligodendrocyte; Myelin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy
    Ito, Mikako
    Ehara, Yuka
    Li, Jin
    Inada, Kosuke
    Ohno, Kinji
    HUMAN GENE THERAPY, 2017, 28 (05) : 428 - 436
  • [12] Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy
    Terrill, Jessica R.
    Grounds, Miranda D.
    Arthur, Peter G.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2015, 66 : 141 - 148
  • [13] Brain glucose metabolism as a neuronal substrate of the abnormal behavioral response to stress in the mdx mouse, a model of Duchenne muscular dystrophy
    Goutal, Sebastien
    Lancien, Marion
    Rivier, Francois
    Tournier, Nicolas
    Vaillend, Cyrille
    NEUROBIOLOGY OF DISEASE, 2025, 204
  • [14] In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
    Stay, Trace L.
    Miterko, Lauren N.
    Arancillo, Marife
    Lin, Tao
    Sillitoe, Roy, V
    DISEASE MODELS & MECHANISMS, 2020, 13 (02)
  • [15] Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Milad, Nadia
    White, Zoe
    Tehrani, Arash Y.
    Sellers, Stephanie
    Rossi, Fabio M. V.
    Bernatchez, Pascal
    SKELETAL MUSCLE, 2017, 7
  • [16] Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
    Denti, MA
    Rosa, A
    D'Antona, G
    Sthandier, O
    De Angelis, FG
    Nicoletti, C
    Allocca, M
    Pansarasa, O
    Parente, V
    Musarò, A
    Auricchio, A
    Bottinelli, R
    Bozzoni, I
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) : 3758 - 3763
  • [17] Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
    Nadia Milad
    Zoe White
    Arash Y. Tehrani
    Stephanie Sellers
    Fabio M.V. Rossi
    Pascal Bernatchez
    Skeletal Muscle, 7
  • [18] Animal Models of Duchenne Muscular Dystrophy, with Special Reference to the mdx Mouse
    Blain, Alison
    Greally, Elizabeth
    Laval, Steve
    Blamire, Andrew
    MacGowan, Guy
    Straub, Volker
    BIOCYBERNETICS AND BIOMEDICAL ENGINEERING, 2012, 32 (04) : 3 - 15
  • [19] Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of duchenne muscular dystrophy
    Marques, Maria Julia
    Ferretti, Renato
    Vomero, Viviane Urbini
    Minatel, Elaine
    Neto, Humberto Santo
    MUSCLE & NERVE, 2007, 35 (03) : 349 - 353
  • [20] Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy
    Reutenauer, J.
    Dorchies, O. M.
    Patthey-Vuadens, O.
    Vuagniaux, G.
    Ruegg, U. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (04) : 574 - 584
12345